Skip to main content
. 2022 Mar 23;11(7):1769. doi: 10.3390/jcm11071769

Table 3.

Comparison of AT1R serum concentration between the groups depending on the selected variables.

Variable AT1R Concentration p *
COVID-19 Recovered (n = 40) Non-COVID-19 (n = 42)
M Me Min Max Q1 Q3 SD M Me Min Max Q1 Q3 SD
Sex M 3.03 2.99 0.28 7.19 1.48 4.32 2.03 3.25 2.74 0.20 6.71 1.52 5.36 2.26 0.63
F 3.49 3.05 1.35 8.43 2.48 3.95 1.64 4.07 3.44 0.20 8.53 2.86 5.44 2.35 0.30
p-value * 0.48 0.37
Blood group O 4.02 3.98 1.82 5.55 3.43 5.31 1.52 3.19 3.13 0.49 6.55 1.17 5.45 2.21 1.00
AB 4.41 3.95 1.33 8.43 2.48 5.88 2.82 2.06 1.96 0.20 4.02 0.20 4.02 1.91 1.00
A 2.59 2.87 0.88 5.04 1.78 3.05 1.02 4.91 4.90 1.15 8.53 2.68 7.14 2.52 0.08
B 3.91 3.76 1.35 7.19 2.92 4.69 1.74 2.73 3.35 0.20 3.89 1.95 3.57 1.40 0.96
p-value ** 0.72 0.42
Rh 3.57 2.88 1.35 7.19 1.56 5.59 2.67 3.13 3.35 0.49 8.13 1.13 3.89 2.30 0.62
+ 3.33 3.05 0.88 8.43 2.34 3.95 1.61 3.91 3.32 0.20 8.53 2.06 5.79 2.39 0.34
p-value * 0.98 0.41
Hypertension No 3.23 2.99 0.28 8.43 1.80 3.98 1.77 3.86 3.42 0.20 8.53 1.98 5.44 2.28 0.23
Yes 3.71 3.43 1.78 7.19 1.82 4.33 2.23 2.44 1.13 0.20 5.99 0.20 5.99 3.11 0.37
p-value * 0.59 0.31
Diabetes No 3.27 2.99 0.28 8.43 1.80 3.98 1.82 3.70 3.32 0.20 8.53 1.96 5.23 2.33 0.41
Yes 4.33 4.33 4.33 4.33 4.33 4.33 - 5.99 5.99 5.99 5.99 5.99 5.99 - -
p-value * - -
Thyroid disease No 3.24 2.98 0.28 8.43 1.79 4.15 1.86 3.67 3.42 0.20 8.53 1.91 5.44 2.30 0.42
Yes 3.79 3.19 2.91 5.88 2.95 4.63 1.41 4.84 3.28 3.11 8.13 3.11 8.13 2.85 0.60
p-value * 0.43 0.56

Abbreviations: n, number of participants; M, mean; Me, median; Min, minimum value; Max, maximum value; Q1, lower quartile; Q3, upper quartile; SD, standard deviation; AT1R, angiotensin II type 1 receptor; M, male; F, female; p, level of statistical significance. Notes: * Mann–Whitney U test; ** Kruskal–Wallis test; Bonferroni correction was used for all comparisons.